| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1185/030079905X43640 |
| P8608 | Fatcat ID | release_r52tc26lpva7pkdwyu26qgxjty |
| P698 | PubMed publication ID | 15969868 |
| P50 | author | Georgia D Montouris | Q47820452 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 693-701 | |
| P577 | publication date | 2005-05-01 | |
| P1433 | published in | Current Medical Research and Opinion | Q5195063 |
| P1476 | title | Safety of the newer antiepileptic drug oxcarbazepine during pregnancy | |
| P478 | volume | 21 |
| Q36418149 | Abrupt discontinuation of psychotropic drugs following confirmation of pregnancy: a risky practice |
| Q55716842 | Antiepileptic drugs and pregnancy outcomes. |
| Q36319420 | Best practice guidelines for the management of women with epilepsy |
| Q36292532 | Birth defects after prenatal exposure to antiepileptic drugs |
| Q36511300 | Birth defects and epilepsy medication |
| Q46984904 | Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium |
| Q33270669 | EURAP outcomes for seizure control during pregnancy: useful and encouraging data |
| Q41933910 | Effects of Levetiracetam on neural tube development and closure of the chick embryos in ovo. |
| Q36969393 | Epilepsy drugs and effects on fetal development: Potential mechanisms |
| Q47235722 | Eslicarbazepine acetate in epilepsies with focal and secondary generalised seizures: systematic review of current evidence. |
| Q57820341 | Gebelikte Psikotrop İlaç Kullanımı: Bir Güncelleme |
| Q30443028 | Impact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research |
| Q42351396 | In Utero Oxcarbazepine Exposure and Neonatal Abstinence Syndrome: Case Report and Brief Review of the Literature |
| Q34722379 | Management of epilepsy during pregnancy |
| Q36476623 | Management of epilepsy in women of childbearing age: practical recommendations |
| Q34977403 | Managing epilepsy in women of childbearing age. |
| Q36476778 | Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers |
| Q34267151 | Teratogenic effects of antiepileptic drugs |
| Q84581302 | Teratogenic effects of antiepileptic drugs |
| Q37262946 | Teratogenicity of antiepileptic medications |
| Q36811532 | The adverse effects of antiepileptic drugs in children |
| Q47633139 | The neurotoxic effects of prenatal gabapentin and oxcarbazepine exposure on newborn rats |
| Q36577270 | Therapy insight: clinical management of pregnant women with epilepsy |
| Q38194574 | Treating epilepsy in pregnant women |
| Q43267058 | Treatment considerations during pregnancy for women with epilepsy |
| Q46209070 | Unilateral radius aplasia due to lamotrigine and oxcarbazepine use in pregnancy |
| Q80606154 | [Treatment of epilepsy in adults. Options and strategies] |
Search more.